Vontobel Holding Ltd. Boosts Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Vontobel Holding Ltd. lifted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 20.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,959 shares of the financial services provider’s stock after buying an additional 497 shares during the quarter. Vontobel Holding Ltd.’s holdings in iShares Biotechnology ETF were worth $391,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of IBB. Sequoia Financial Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 8.3% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 2,608 shares of the financial services provider’s stock valued at $380,000 after buying an additional 199 shares during the period. Eastern Bank purchased a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $65,000. SOL Capital Management CO increased its holdings in iShares Biotechnology ETF by 0.5% during the 3rd quarter. SOL Capital Management CO now owns 35,165 shares of the financial services provider’s stock worth $5,120,000 after purchasing an additional 190 shares during the period. Lyell Wealth Management LP increased its holdings in iShares Biotechnology ETF by 3.4% during the 3rd quarter. Lyell Wealth Management LP now owns 22,274 shares of the financial services provider’s stock worth $3,243,000 after purchasing an additional 735 shares during the period. Finally, NorthCrest Asset Manangement LLC increased its holdings in iShares Biotechnology ETF by 12.3% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 3,290 shares of the financial services provider’s stock worth $479,000 after purchasing an additional 360 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $139.43 on Friday. The stock’s 50-day moving average is $135.56 and its two-hundred day moving average is $140.78. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.